CAS
LH icon

CTC Alternative Strategies’s Labcorp LH Stock Holding History

CTC Alternative Strategies’s Portfolio LH Stock Details LH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-3,725
Closed -$314K – 242
2014
Q1 		$314K Buy
+3,725
New +$297K 0.18% 53

Other funds holding LH

DSA
Davis Selected Advisers Tucson, Arizona $21.8B AUM 23.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
PIM
Perkins Investment Management Chicago, Illinois $8.09B AUM 25.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

CTC Alternative Strategies's LH Position: Q2 2014 in Review

CTC Alternative Strategies sold out of Labcorp (LH) in Q2 2014, closing a stake of 3,725 shares — an estimated $314K sold.

CTC Alternative Strategies first reported a position in LH in Q1 2014 and held it in 1 quarter. The position peaked at $314K in Q1 2014. 523 funds tracked by Wall St. Rank hold LH as of Q2 2014.

  • CTC Alternative Strategies reported no remaining Labcorp position as of Q2 2014 after selling out during the quarter.
  • CTC Alternative Strategies sold 3,725 Labcorp shares in Q2 2014, an estimated $314K.
  • CTC Alternative Strategies first reported a position in Labcorp in Q1 2014 and held it in 1 quarter.
  • CTC Alternative Strategies's Labcorp position peaked at $314K in Q1 2014.
  • 523 funds tracked by Wall St. Rank held Labcorp as of Q2 2014.

Based on CTC Alternative Strategies's 13F filing for Q2 2014, filed 22 Jul 2014.